Archives of Clinical Infectious Diseases

Published by: Kowsar

Investigation of Fungal Colonization Among Iranian Patients with Idiopathic Pulmonary Fibrosis; Molecular Identification and Antifungal Susceptibility Pattern

Maryam Roudbary 1 , * , Hossein Keyvani 2 , Seyed Ali Javad Mousavi 3 , Maryam Esghaei 2 , Shahla Roudbarmohammadi 4 , Neda Hedayati 5 , Ghazaleh Salehabadi 5 , Mehraban Falahati 1 and Mahtab Ashrafi khozani 1
Authors Information
1 Department of Medical Mycology and Parasitology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
3 Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4 Department of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
5 Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Clinical Infectious Diseases: 14 (2); e65758
  • Published Online: April 10, 2019
  • Article Type: Research Article
  • Received: December 31, 2017
  • Revised: August 1, 2018
  • Accepted: November 5, 2018
  • DOI: 10.5812/archcid.65758

To Cite: Roudbary M, Keyvani H, Mousavi S A J , Esghaei M, Roudbarmohammadi S, et al. Investigation of Fungal Colonization Among Iranian Patients with Idiopathic Pulmonary Fibrosis; Molecular Identification and Antifungal Susceptibility Pattern, Arch Clin Infect Dis. Online ahead of Print ; 14(2):e65758. doi: 10.5812/archcid.65758.

Copyright © 2019, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949-61. doi: 10.1016/S0140-6736(11)60052-4. [PubMed: 21719092].
  • 2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824. doi: 10.1164/rccm.2009-040GL. [PubMed: 21471066]. [PubMed Central: PMC5450933].
  • 3. Daniels CE, Ryu JH. Treatment of idiopathic pulmonary fibrosis. Semin Respir Crit Care Med. 2006;27(6):668-76. doi: 10.1055/s-2006-957338. [PubMed: 17195143].
  • 4. Salisbury ML, Xia M, Zhou Y, Murray S, Tayob N, Brown KK, et al. Idiopathic pulmonary fibrosis: Gender-age-physiology index stage for predicting future lung function decline. Chest. 2016;149(2):491-8. doi: 10.1378/chest.15-0530. [PubMed: 26425858]. [PubMed Central: PMC4944785].
  • 5. Javadi A, Adibi P, Ataei B, Nokhodian Z, Yaran M. Surveillance of acute respiratory infections among outpatients: A pilot study in Isfahan city. J Res Med Sci. 2015;20(2):115-21. [PubMed: 25983761]. [PubMed Central: PMC4400703].
  • 6. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071-82. doi: 10.1056/NEJMoa1402584. [PubMed: 24836310].
  • 7. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15(2):194-222. doi: 10.1128/CMR.15.2.194-222.2002. [PubMed: 11932230]. [PubMed Central: PMC118069].
  • 8. Molyneaux PL, Maher TM. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. Eur Respir Rev. 2013;22(129):376-81. doi: 10.1183/09059180.00000713. [PubMed: 23997064].
  • 9. Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014;190(8):906-13. doi: 10.1164/rccm.201403-0541OC. [PubMed: 25184687]. [PubMed Central: PMC4299577].
  • 10. Gungor O, Tamay Z, Guler N, Erturan Z. Frequency of fungi in respiratory samples from Turkish cystic fibrosis patients. Mycoses. 2013;56(2):123-9. doi: 10.1111/j.1439-0507.2012.02221.x. [PubMed: 22747891].
  • 11. Gammelsrud KW, Sandven P, Hoiby EA, Sandvik L, Brandtzaeg P, Gaustad P. Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls. Clin Microbiol Infect. 2011;17(12):1875-81. doi: 10.1111/j.1469-0691.2011.03528.x. [PubMed: 21745258].
  • 12. Santos A, Galdino ACM, Mello TP, Ramos LS, Branquinha MH, Bolognese AM, et al. What are the advantages of living in a community? A microbial biofilm perspective!. Mem Inst Oswaldo Cruz. 2018;113(9). e180212. doi: 10.1590/0074-02760180212. [PubMed: 30066753]. [PubMed Central: PMC6057313].
  • 13. Desai JV, Mitchell AP, Andes DR. Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harb Perspect Med. 2014;4(10). doi: 10.1101/cshperspect.a019729. [PubMed: 25274758]. [PubMed Central: PMC4200207].
  • 14. Horre R, Schaal KP, Siekmeier R, Sterzik B, de Hoog GS, Schnitzler N. Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis. A prospective study. Respiration. 2004;71(4):360-6. doi: 10.1159/000079640. [PubMed: 15316209].
  • 15. Liguori G, Di Onofrio V, Lucariello A, Galle F, Signoriello G, Colella G, et al. Oral candidiasis: A comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral Microbiol Immunol. 2009;24(1):76-8. doi: 10.1111/j.1399-302X.2008.00447.x. [PubMed: 19121074].
  • 16. Roudbarmohammadi S, Roudbary M, Bakhshi B, Katiraee F, Mohammadi R, Falahati M. ALS1 and ALS3 gene expression and biofilm formation in Candida albicans isolated from vulvovaginal candidiasis. Adv Biomed Res. 2016;5:105. doi: 10.4103/2277-9175.183666. [PubMed: 27376044]. [PubMed Central: PMC4918214].
  • 17. Esteve-Zarzoso B, Belloch C, Uruburu F, Querol A. Identification of yeasts by RFLP analysis of the 5.8S rRNA gene and the two ribosomal internal transcribed spacers. Int J Syst Bacteriol. 1999;49 Pt 1:329-37. doi: 10.1099/00207713-49-1-329. [PubMed: 10028278].
  • 18. Wayne P. Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard; CLSI document M27-A3.CLSI 2008a. 28. 2008.
  • 19. Santos ER, Dal Forno CF, Hernandez MG, Kubica TF, Venturini TP, Chassot F, et al. Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints. Rev Inst Med Trop Sao Paulo. 2014;56(6):477-82. doi: 10.1590/S0036-46652014000600004. [PubMed: 25351540]. [PubMed Central: PMC4296866].
  • 20. Windisch W, Schildgen V, Malecki M, Lenz J, Brockmann M, Karagiannidis C, et al. Detection of HBoV DNA in idiopathic lung fibrosis, Cologne, Germany. J Clin Virol. 2013;58(1):325-7. doi: 10.1016/j.jcv.2013.05.020. [PubMed: 23806665].
  • 21. Ringshausen FC, Tan AY, Allander T, Borg I, Arinir U, Kronsbein J, et al. Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009;4:111-7. doi: 10.2147/COPD.S4801. [PubMed: 19436697]. [PubMed Central: PMC2672801].
  • 22. Wurzel DF, Marchant JM, Clark JE, Mackay IM, Wang CY, Sloots TP, et al. Respiratory virus detection in nasopharyngeal aspirate versus bronchoalveolar lavage is dependent on virus type in children with chronic respiratory symptoms. J Clin Virol. 2013;58(4):683-8. doi: 10.1016/j.jcv.2013.09.016. [PubMed: 24125830].
  • 23. Ushiki A, Yamazaki Y, Hama M, Yasuo M, Hanaoka M, Kubo K. Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia. Respir Investig. 2014;52(1):65-70. doi: 10.1016/j.resinv.2013.07.005. [PubMed: 24388373].
  • 24. Moore BB, Moore TA. Viruses in idiopathic pulmonary fibrosis. Etiology and exacerbation. Ann Am Thorac Soc. 2015;12 Suppl 2:S186-92. doi: 10.1513/AnnalsATS.201502-088AW. [PubMed: 26595738]. [PubMed Central: PMC4722834].
  • 25. Moradi P, Keyvani H, Javad Mousavi SA, Karbalaie Niya MH, Esghaei M, Bokharaei-Salim F, et al. Investigation of viral infection in idiopathic pulmonary fibrosis among Iranian patients in Tehran. Microb Pathog. 2017;104:171-4. doi: 10.1016/j.micpath.2017.01.030. [PubMed: 28115263].
  • 26. Peltroche-Llacsahuanga H, Dohmen H, Haase G. Recovery of Candida dubliniensis from sputum of cystic fibrosis patients. Mycoses. 2002;45(1-2):15-8. doi: 10.1046/j.0933-7407.2001.00719.x. [PubMed: 11856431].
  • 27. Loreto ES, Scheid LA, Nogueira CW, Zeni G, Santurio JM, Alves SH. Candida dubliniensis: Epidemiology and phenotypic methods for identification. Mycopathologia. 2010;169(6):431-43. doi: 10.1007/s11046-010-9286-5. [PubMed: 20490751].
  • 28. Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. Med Mycol. 2009;47(4):387-97. doi: 10.1080/13693780802609604. [PubMed: 19107638].
  • 29. Kumar N, Mishra M, Singhal A, Kaur J, Tripathi V. Aspergilloma coexisting with idiopathic pulmonary fibrosis: A rare occurrence. J Postgrad Med. 2013;59(2):145-8. doi: 10.4103/0022-3859.113841. [PubMed: 23793319].
  • 30. Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2000;44(10):2693-700. doi: 10.1128/AAC.44.10.2693-2700.2000. [PubMed: 10991846]. [PubMed Central: PMC90137].
  • 31. Tscherner M, Schwarzmüller T, Kuchler K. Pathogenesis and antifungal drug resistance of the human fungal pathogen Candida glabrata. Pharmaceuticals. 2011;4(1):169-86. doi: 10.3390/ph4010169.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments